Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history and the previous revision v3.6.4 was removed, updating the visible version history of the page.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedA new release version (v3.6.4) was added to the page’s history. The previous version (v3.6.3) was removed, signaling a minor platform update reflected in the record history.SummaryDifference0.1%

- Check50 days agoChange DetectedThe history now shows a new system revision labeled v3.6.3, replacing the previous v3.6.2, indicating a platform update rather than modifications to the study record.SummaryDifference0.1%

- Check57 days agoChange DetectedThe record history now includes a new revision entry (v3.6.2) superseding the previous (v3.6.0). This indicates an update to the page history on ClinicalTrials.gov rather than a change to the study data.SummaryDifference0.1%

- Check71 days agoChange DetectedThe recruitment notice now states that no participants are being sought, signaling that enrollment for the study has ended. A new revision tag (v3.6.0) was added to the record to capture this update in the study history.SummaryDifference0.2%

- Check78 days agoChange DetectedThe history now shows the latest revision as v3.5.5, with the prior v3.5.4 removed. This reflects an update to the record's revision history rather than a change to trial content.SummaryDifference0.1%

Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.